Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05417425 · ClinicalTrials.gov registry record · Phase 1
Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers
A Phase 1 study, sponsored by Omeza.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT05417425 is a Phase 1 study that has completed, run by Omeza. The registered enrollment target is 25 participants.
The verdict
NCT05417425, a Phase 1 study, has completed, sponsored by Omeza.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study is to evaluate the efficacy of OCM™ used in combination with off-loading devices for the treatment of diabetic foot ulcers.
Interventions
- COMBINATION_PRODUCT Omeza collagen matrix, Omeza lidocaine lavage, Omeza skin protectant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05417425
The ClinicalTrials.gov registry entry for NCT05417425 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Omeza, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omeza collagen matrix, Omeza lidocaine lavage, Omeza skin protectant is the first listed.
NCT05417425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05417425 about?
NCT05417425 is a clinical study titled "Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers". This study is to evaluate the efficacy of OCM™ used in combination with off-loading devices for the treatment of diabetic foot ulcers.
What is the current status of trial NCT05417425?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2022-09-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05417425?
The interventions under investigation include: Omeza collagen matrix, Omeza lidocaine lavage, Omeza skin protectant (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05417425?
This trial is sponsored by Omeza, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.